Navigation Links
Estrogen pills can benefit women with metastatic breast cancer
Date:12/11/2008

For breast cancer survivors, the idea of taking estrogen pills is almost a taboo. In fact, their doctors give them drugs to get rid of the hormone because it can fuel the growth of breast cancer. So these women would probably be surprised by the approach taken by breast cancer physician Matthew Ellis, M.B., Ph.D., associate professor of medicine at Washington University School of Medicine in St. Louis he has demonstrated that estrogen therapy can help control metastatic breast cancer.

In a study presented at the 31st annual San Antonio Breast Cancer Symposium, he showed that for about a third of the 66 participants women with metastatic breast cancer that had developed resistance to standard estrogen-lowering therapy a daily dose of estrogen could stop the growth of their tumors or even cause them to shrink. The study was funded by the Avon Foundation through the National Cancer Institute and included six cancer centers in the United States.

Ellis believes that estrogen therapy offers an appealing alternative to chemotherapy for metastatic breast cancer that has become resistant to estrogen-lowering agents called aromatase inhibitors, such as exemestane, anastrazole and letrozole. These drugs deplete the body of estrogen and are standard treatments for hormone-receptor positive breast cancers, which account for about 75 percent of breast cancer cases.

"By stabilizing or shrinking tumors in some women with metastatic breast cancer, estrogen therapy can relieve pain and other symptoms of cancer and can potentially prolong lives," says Ellis, an oncologist with the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital. "And unlike chemotherapy, estrogen enhances the quality of life. For many of our patients, their hot flashes disappear, and they lose other symptoms of menopause. It's a natural treatment for breast cancer. Not only that, it's much cheaper than chemotherapy, costing less than a d
'/>"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New link between estrogen and breast cancer
2. UCLA study identifies designer estrogen as potential MS drug
3. Cholesterol byproduct blocks heart health benefits of estrogen
4. Gene May Influence Breast Cancer-Estrogen Link
5. Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
6. Estrogen Levels in Blood Predict Breast Cancers Return
7. Mitochondria play role in pathogenesis of AD and estrogen-induced neuroprotection
8. New study finds adverse effects of estrogen replacement therapy are related to the dose
9. Estrogen Supplements May Raise Odds of Benign Breast Disease
10. Estrogen therapy increases benign breast disease risk
11. Previously unseen switch regulates breast cancer response to estrogen

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...dings has announced that it has become a national ...rgest nonprofit organizations dedicated to arthrit... Delray Beach, FL (Vocus) Novembe...), a company specializing in the marketing and ret...has announced today that is has become a national ...
(Date:11/27/2009)...edical, economic burdens, study predicts , ...r of people with diabetes in the United States is ...tudy predicts. , That would bring the total by ..., up from 23.7 million today. , , At the same ti... triple, the study also warns, rising from an esti...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/27/2009)...anufacturers who use medical load cells at the hea...s by bringing in technology partner Flintec early ...ctive medical manufacturers are calling in Flintec...rojects, ensuring that progress will not be constr...outdated technology. , (P...
(Date:11/26/2009)...ire/ -- With cold and flu season upon us, it,s mor...control the spread of infections and avoid illness...ourselves healthy, but to avoid transmitting illne...C (certified in infection-control), nursing direct...t Hospital for Special Surgery (HSS) in Manhattan....
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
... BRUSSELS and LA GAUDE, France, May 13 IBM (NYSE:...lobal Healthcare Centre of Excellence located in L...com.com/cgi-bin/prnh/20090416/IBMLOGO ) , , Ex...utions that improve care delivery, predict and pre...
... Surgeon receives top score in Carolinas Medical C...13 Dr. Peter J. Capizzi of Stillwater Plastic Sur...he 2008 Carolinas Medical Center-University patien...es the program and selects the honorees. "The pati...
...n U.S., 40 percent of new moms aren,t married, CDC...ay News) -- The number of unmarried women having c... several other countries, according to U.S. health...ng to a report, Changing Patterns of Nonmarital C...
... HOUSTON (May 13, 2009) The beta-carotene in so...ans, according to researchers at Baylor College of... article that appears in the current issue of the ... of creating rice that had beta-carotene -- a vita...
... CEP America,s Longest-Standing Client Congratulat...ious Designation , , EMERYVILLE, Calif., May 13...rs of emergency department (ED) management and sta...entialing Center (ANCC). Only five percent of U.S....
... Voters willing to engage in discussion about trad...nt answers to tough questions about the trade-offs...data released today by the Stanford Center on Long...ds of politics, academia and the public. , , "As ...
Other Medicine News:Health News:IBM Establishes Global Healthcare Centre of Excellence in La Gaude, France 2Health News:IBM Establishes Global Healthcare Centre of Excellence in La Gaude, France 3Health News:Dr. Peter J. Capizzi of Stillwater Plastic Surgery Honored in Patient Satisfaction Survey 2Health News:More Single Women Are Having Babies 2Health News:More Single Women Are Having Babies 3Health News:More Single Women Are Having Babies 4Health News:Palomar Pomerado Health System Achieves National Recognition for Nursing Excellence by the American Nurses Credentialing Center 2Health News:Palomar Pomerado Health System Achieves National Recognition for Nursing Excellence by the American Nurses Credentialing Center 3Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...www.reportlinker.com/p0164220/Pain-Management---Gl... generic drugs, emergence of pain management clini...he pace of growth in the pain management market. H...
(Date:11/25/2009)..., , DELFT, The Netherlands and JOHA...maceuticals, service division and Pyxis Discovery ...ive agreement to jointly market both,companies, se...al chemistry and lead discovery expertise,will be ... medicinal and,synthetic chemistry support to proj...
(Date:11/25/2009)..., , MOUNTAIN VIEW, Calif., Nov. 25 /PRNewsw... Phase II/III clinical data from the Company,s PRO...aluation in Crohn,s disease Trial) of Traficet-EN(... Crohn,s disease demonstrated clinical efficacy wi...he study demonstrated evidence of clinical efficac...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Elseviers PharmaPendium introduces the FDA Classic Collection 47610 1Elseviers PharmaPendium introduces the FDA Classic Collection 47610 2SRI International announces findings from new upper atmospheric radar system for scientific research 8688 1SRI International announces findings from new upper atmospheric radar system for scientific research 8688 2SRI International announces findings from new upper atmospheric radar system for scientific research 8688 3SRI International announces findings from new upper atmospheric radar system for scientific research 8688 4National Partnership to Meet Evaluate Addiction Treatment as Component of New Justice Programs 47608 1National Partnership to Meet Evaluate Addiction Treatment as Component of New Justice Programs 47608 2National Partnership to Meet Evaluate Addiction Treatment as Component of New Justice Programs 47608 3
...MP4 and BMP7 inhibit the,growth of medulloblastoma...,into normal neurons, a finding that may lead to b...March 14 A discovery by St.,Jude Children,s Resea...eat,medulloblastoma, a rare but often fatal childh...rain,s signaling pathways inhibits the growth of t...
...maceuticals,Inc. today announced that enrollment h...ts that evaluates the safety and efficacy of its l...umatoid arthritis (RA). MM-093 is a,recombinant ve...omized, double-blind, placebo-controlled, Phase 2 ...the United States. The objective,of this study is ...
Other Medicine Technology:St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer 2Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis 2
Clinical Xpert™ PDA Medical Reference and Decision-Support Tool
Diagnosoft HARP Cardiac MRI Tagging
VISULAS YAG III Combi Complete Laser Therapy System
...olter Monitoring System, equipped with the latest ...lysis algorithm, Heart Rate Variability analysis a...s with an Epicardia System in place have complete ...suit their needs, and managing their data. The Epi...
Medicine Products: